131 related articles for article (PubMed ID: 38752632)
1. In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer's Disease.
Sun Y; Zhao J; Lu Y; Ngo FY; Shuai B; Zhang ZJ; Feng Y; Rong J
Curr Neuropharmacol; 2024 May; ():. PubMed ID: 38752632
[TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer's Disease.
Qi P; Li J; Gao S; Yuan Y; Sun Y; Liu N; Li Y; Wang G; Chen L; Shi J
Front Aging Neurosci; 2020; 12():589588. PubMed ID: 33192484
[TBL] [Abstract][Full Text] [Related]
3. DAPK1: a Novel Pathology and Treatment Target for Alzheimer's Disease.
Xu LZ; Li BQ; Jia JP
Mol Neurobiol; 2019 Apr; 56(4):2838-2844. PubMed ID: 30062675
[TBL] [Abstract][Full Text] [Related]
4. Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer's Disease.
Chen D; Zhou XZ; Lee TH
Recent Pat Anticancer Drug Discov; 2019; 14(2):144-157. PubMed ID: 30569876
[TBL] [Abstract][Full Text] [Related]
5. Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.
Zhang T; Kim BM; Lee TH
Transl Neurodegener; 2024 Jan; 13(1):4. PubMed ID: 38195518
[TBL] [Abstract][Full Text] [Related]
6. NMDA Receptor GluN2B Subunit Is Involved in Excitotoxicity Mediated by Death-Associated Protein Kinase 1 in Alzheimer's Disease.
Xu LZ; Li BQ; Li FY; Li Y; Qin W; Zhao Y; Jia JP
J Alzheimers Dis; 2023; 91(2):877-893. PubMed ID: 36502323
[TBL] [Abstract][Full Text] [Related]
7. In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.
Islam MR; Zaman A; Jahan I; Chakravorty R; Chakraborty S
J Young Pharm; 2013 Dec; 5(4):173-9. PubMed ID: 24563598
[TBL] [Abstract][Full Text] [Related]
8. Death-Associated Protein Kinase 1 Phosphorylation in Neuronal Cell Death and Neurodegenerative Disease.
Kim N; Chen D; Zhou XZ; Lee TH
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248062
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential death-associated protein kinase-1 (DAPK1) inhibitors by an integrated ligand-based and structure-based computational drug design approach.
Ghosh P; Singh R; Ganeshpurkar A; Swetha R; Kumar D; Singh SK; Kumar A
J Biomol Struct Dyn; 2023 Dec; 41(20):10785-10797. PubMed ID: 36576199
[TBL] [Abstract][Full Text] [Related]
10. Identification of phytochemicals from North African plants for treating Alzheimer's diseases and of their molecular targets by in silico network pharmacology approach.
Raafat K
J Tradit Complement Med; 2021 May; 11(3):268-278. PubMed ID: 34012873
[TBL] [Abstract][Full Text] [Related]
11. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
[TBL] [Abstract][Full Text] [Related]
12. Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1.
Shu S; Zhu H; Tang N; Chen W; Li X; Li H; Pei L; Liu D; Mu Y; Tian Q; Zhu LQ; Lu Y
J Neurosci; 2016 Oct; 36(42):10843-10852. PubMed ID: 27798139
[TBL] [Abstract][Full Text] [Related]
13. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
Ambure P; Bhat J; Puzyn T; Roy K
J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
[TBL] [Abstract][Full Text] [Related]
14. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.
Wang L; Shui X; Mei Y; Xia Y; Lan G; Hu L; Zhang M; Gan CL; Li R; Tian Y; Wang Q; Gu X; Chen D; Zhang T; Lee TH
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887339
[TBL] [Abstract][Full Text] [Related]
15. Melatonin directly binds and inhibits death-associated protein kinase 1 function in Alzheimer's disease.
Chen D; Mei Y; Kim N; Lan G; Gan CL; Fan F; Zhang T; Xia Y; Wang L; Lin C; Ke F; Zhou XZ; Lu KP; Lee TH
J Pineal Res; 2020 Sep; 69(2):e12665. PubMed ID: 32358852
[TBL] [Abstract][Full Text] [Related]
16. Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an
Firoz A; Talwar P
J Biomol Struct Dyn; 2024 Jul; 42(11):5686-5698. PubMed ID: 37387600
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Interaction of Human Ferritin with Quercetin and Naringenin: Implication of Natural Products in Neurodegenerative Diseases: Molecular Docking and Dynamics Simulation Insight.
Shamsi A; Shahwan M; Khan MS; Husain FM; Alhumaydhi FA; Aljohani ASM; Rehman MT; Hassan MI; Islam A
ACS Omega; 2021 Mar; 6(11):7922-7930. PubMed ID: 33778303
[TBL] [Abstract][Full Text] [Related]
18. Prediction of GluN2B-CT
Tu G; Fu T; Yang F; Yao L; Xue W; Zhu F
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463177
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrol.
Yokoyama T; Suzuki R; Mizuguchi M
IUCrJ; 2021 Jan; 8(Pt 1):131-138. PubMed ID: 33520249
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology to unveil the mechanism of suanzaoren decoction in the treatment of alzheimer's with diabetes.
Chen T; Lei Y; Li M; Liu X; Zhang L; Cai F; Gong X; Zhang R
Hereditas; 2024 Jan; 161(1):2. PubMed ID: 38167125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
